Hostname: page-component-5c6d5d7d68-wtssw Total loading time: 0 Render date: 2024-08-17T23:36:19.304Z Has data issue: false hasContentIssue false

P-93 - Pharmacological Therapy and its Side Effects in Patients Undergoing Addiction Treatment

Published online by Cambridge University Press:  15 April 2020

A.M. Silva
Affiliation:
Cardiology, São Paulo, Brazil
M.L. Pequeno
Affiliation:
Instituto de Ensino e Pesquisa, Albert Einstein Hospital, São Paulo, Brazil
M.D.F. Gonçalves
Affiliation:
Instituto de Ensino e Pesquisa, Albert Einstein Hospital, São Paulo, Brazil
F.J. Ropero Pelaez
Affiliation:
Mathematical Computation and Cognition, UFABC
V.D. Gonçalves
Affiliation:
Radiotherapy, Albert Einstein Hospital, São Paulo, Brazil
J.A. Gonçalves
Affiliation:
Instituto de Ensino e Pesquisa, Albert Einstein Hospital, São Paulo, Brazil
M.C.B. Nascimento
Affiliation:
Instituto de Ensino e Pesquisa, Albert Einstein Hospital, São Paulo, Brazil
S.F. Taniguchi
Affiliation:
Instituto de Ensino e Pesquisa, Albert Einstein Hospital, São Paulo, Brazil

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Patients’ compliance to illicit drugs addiction's treatment, is a limiting factor for the effectiveness of these patients’ treatment.

Objective

The aim of this research was to study the pharmacological therapy and its side effects, in patients undergoing addiction treatment.

Results

This study selected 31 patients with mean age of 33,61 ± 1,90 years old enrolled in a public mental health service with psychotic disorder related to the use of cocaine, crack an alcohol.

Patients under this study were addicted to alcohol (61,29%), cocaine, crack or the association of both (38,71%).

Effects related to the use of cocaine were delirium/hallucination (50%), cardiovascular effects (27,76%), psychomotor agitation (11,12%). (No effects reported 11,10%).

Patient-reported, crack-related effects were delirium and hallucination (50%), cardiovascular effects (37,50%). (No effects reported 12,50%).

Psychosis (73,08%), aggressive behavior (7,69%), abstinence syndrome (11,54%), were associated to the use of alcohol. (No side effects reported 7,69%)

The pharmacological treatment to these patients were typical neuroleptics (41,94%), atypical neuroleptics (22,58%), typical and atypical neuroleptics associated (29,03%), (No treatment 6,45%).

Side effects related to pharmacological treatment were extrapyramidal effects (56,24%), delirium/hallucination (43,74%), memory impairment (34,37%), anxiety(31,25%),attention deficit (21,87%), psychotic depression (12,50%), verbal communication deficit (3,12%).

These effects were treated with biperiden (58,34%), promethazine or benzodiazepines (25,00%). (No treatment was done in16,67%).

Conclusions

The use of neuroleptics in the treatment of psychotic disorders due to the use of illicit drugs should be evaluated. The side effects related to the neuroleptics must be carefully controlled in order to guarantee the patients' compliance to the treatment.

Type
Abstract
Copyright
Copyright © European Psychiatric Association 2012
Submit a response

Comments

No Comments have been published for this article.